HOME CONTACT US SITE MAP ABOUT US DRUG CANDIDATES RESEARCH PROGRAMS GPCR TECHNOLOGY INVESTORS CAREERS   Lorcaserin Published in New England Journal of Medicine The lorcaserin Phase 3 BLOOM trial was published in the New England Journal of Medicine. Lorcaserin for Weight Management Our most advanced drug candidate, lorcaserin, is intended for weight management, including weight loss and maintenance of weight loss. Pipeline Pipeline of novel and selective drug candidates developed independently and with collaborators. Investors Our vision is to be the recognized world leader in GPCR drug discovery and development. Press Releases More... 2012 Annual Stockholders Meeting 2011 Annual Report (PDF) 2012 Proxy Statement (PDF) If you do not have Adobe® Reader, download it here. It is available without charge from Adobe®. Arena is not responsible for the content of this linked page.   This page last updated 05/09/2012 Additional Information regarding Arena is available in its SEC filings © Copyright 2000-2012 Arena Pharmaceuticals, Inc. All Rights Reserverd Terms and Conditions Privacy Statement ABOUT US DRUG CANDIDATES RESEARCH PROGRAMS GPCR TECHNOLOGY INVESTORS CAREERS